Literature DB >> 33605000

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

Biykem Bozkurt, Andrew J S Coats, Hiroyuki Tsutsui, Ca Magdy Abdelhamid, Stamatis Adamopoulos, Nancy Albert, Stefan D Anker, John Atherton, Michael Böhm, Javed Butler, Mark H Drazner, G Michael Felker, Gerasimos Filippatos, Mona Fiuzat, Gregg C Fonarow, Juan-Esteban Gomez-Mesa, Paul Heidenreich, Teruhiko Imamura, Ewa A Jankowska, James Januzzi, Prateeti Khazanie, Koichiro Kinugawa, Carolyn S P Lam, Yuya Matsue, Marco Metra, Tomohito Ohtani, Massimo Francesco Piepoli, Piotr Ponikowski, Giuseppe M C Rosano, Yasushi Sakata, Petar Seferović, Randall C Starling, John R Teerlink, Orly Vardeny, Kazuhiro Yamamoto, Clyde Yancy, Jian Zhang, Shelley Zieroth.   

Abstract

In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre-HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41-49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
© 2021 European Society of Cardiology and Elsevier, Inc.

Entities:  

Keywords:  Cardiomyopathy; Definition of heart failure; HFmrEF; HFpEF; HFrEF; Heart failure; Stages of heart failure

Mesh:

Year:  2021        PMID: 33605000     DOI: 10.1002/ejhf.2115

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  95 in total

Review 1.  NLRP3 Inflammasome: a Novel Insight into Heart Failure.

Authors:  Yunjiao Wang; Yanyang Li; Wanqin Zhang; Zhuo Yuan; Shichao Lv; Junping Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-13       Impact factor: 4.132

2.  [Guideline S1: Long COVID: Diagnostics and treatment strategies].

Authors:  Susanne Rabady; Johann Altenberger; Markus Brose; Doris-Maria Denk-Linnert; Elisabeth Fertl; Florian Götzinger; Maria de la Cruz Gomez Pellin; Benedikt Hofbaur; Kathryn Hoffmann; Renate Hoffmann-Dorninger; Rembert Koczulla; Oliver Lammel; Bernd Lamprecht; Judith Löffler-Ragg; Christian A Müller; Stefanie Poggenburg; Hans Rittmannsberger; Paul Sator; Volker Strenger; Karin Vonbank; Johannes Wancata; Thomas Weber; Jörg Weber; Günter Weiss; Maria Wendler; Ralf-Harun Zwick
Journal:  Wien Klin Wochenschr       Date:  2021-12-01       Impact factor: 1.704

3.  Diastolic function in patients with heart failure with preserved ejection fraction and atrial fibrillation: impact of diabetes.

Authors:  Ruxandra-Nicoleta Horodinschi; Camelia Cristina Diaconu
Journal:  Am J Cardiovasc Dis       Date:  2021-10-25

4.  Foreword.

Authors: 
Journal:  Interv Cardiol       Date:  2022-06-29

Review 5.  [Implantation of mechanical circulatory support systems and heart transplantation in patients with end-stage heart failure : Consensus paper of the DGK, DGTHG].

Authors:  P Christian Schulze; Markus J Barten; Udo Boeken; Gloria Färber; Christian M Hagl; Christian Jung; David Leistner; Evgenij Potapov; Johann Bauersachs; Philip Raake; Nils Reiss; Diyar Saeed; David Schibilsky; Stefan Störk; Christian Veltmann; Andreas J Rieth; Jan Gummert
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-07-11       Impact factor: 1.552

Review 6.  Imaging of heart disease in women: review and case presentation.

Authors:  Nidaa Mikail; Alexia Rossi; Susan Bengs; Ahmed Haider; Barbara E Stähli; Angela Portmann; Alessio Imperiale; Valerie Treyer; Alexander Meisel; Aju P Pazhenkottil; Michael Messerli; Vera Regitz-Zagrosek; Philipp A Kaufmann; Ronny R Buechel; Cathérine Gebhard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-17       Impact factor: 10.057

7.  Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.

Authors:  Fabiana G Marcondes-Braga; Lídia Ana Zytynski Moura; Victor Sarli Issa; Jefferson Luis Vieira; Luis Eduardo Rohde; Marcus Vinícius Simões; Miguel Morita Fernandes-Silva; Salvador Rassi; Silvia Marinho Martins Alves; Denilson Campos de Albuquerque; Dirceu Rodrigues de Almeida; Edimar Alcides Bocchi; Felix José Alvarez Ramires; Fernando Bacal; João Manoel Rossi Neto; Luiz Claudio Danzmann; Marcelo Westerlund Montera; Mucio Tavares de Oliveira Junior; Nadine Clausell; Odilson Marcos Silvestre; Reinaldo Bulgarelli Bestetti; Sabrina Bernadez-Pereira; Aguinaldo F Freitas; Andréia Biolo; Antonio Carlos Pereira Barretto; Antônio José Lagoeiro Jorge; Bruno Biselli; Carlos Eduardo Lucena Montenegro; Edval Gomes Dos Santos Júnior; Estêvão Lanna Figueiredo; Fábio Fernandes; Fabio Serra Silveira; Fernando Antibas Atik; Flávio de Souza Brito; Germano Emílio Conceição Souza; Gustavo Calado de Aguiar Ribeiro; Humberto Villacorta; João David de Souza Neto; Livia Adams Goldraich; Luís Beck-da-Silva; Manoel Fernandes Canesin; Marcelo Imbroinise Bittencourt; Marcely Gimenes Bonatto; Maria da Consolação Vieira Moreira; Mônica Samuel Avila; Otavio Rizzi Coelho Filho; Pedro Vellosa Schwartzmann; Ricardo Mourilhe-Rocha; Sandrigo Mangini; Silvia Moreira Ayub Ferreira; José Albuquerque de Figueiredo Neto; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

Review 8.  The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review.

Authors:  Haneul Cho; Xiao-Xiao Zhao; Sora Lee; Jong Shin Woo; Min-Young Song; Xian Wu Cheng; Kyung Hye Lee; Weon Kim
Journal:  Am J Cardiovasc Drugs       Date:  2021-06-21       Impact factor: 3.571

9.  Progressive Heart Failure and Death as the Initial Manifestation of NK/T-Cell Lymphoma: A Case Report and Literature Review.

Authors:  Ziyu Zhang; Shuai Wang; Qingchun Liang; Daoquan Peng
Journal:  Front Cardiovasc Med       Date:  2021-06-24

Review 10.  Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction.

Authors:  Micha T Maeder; Lukas Weber; Marc Buser; Roman Brenner; Lucas Joerg; Hans Rickli
Journal:  Front Cardiovasc Med       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.